Company: APXIF
Filing Date: 2025-07-18
Form Type: F-4/A
Source: 0001213900-25-065703
Chunk: 185

Company: APx Acquisition Corp. I
Filing Date: 2025-07-18
Form: F-4/A
Chunk 185
---
 leverage and market perceptions regarding the same; •the level of short interest in our shares, and the effect of short sellers on the price of our shares; •actual or anticipated changes in regulatory oversight of our business; •additions or departures of key management or other personnel; •disputes or other developments related to our intellectual property or other proprietary rights, including litigation; •changes in reimbursement by current or potential payers; •general economic and market conditions; and •issuances of significant amounts of our ordinary shares. 71 In addition, the stock market in general, and the market for shares of life sciences and technology companies in particular, has experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of those companies. Broad market and industry factors, including the COVID -19pandemic, as well as general economic, political and geopolitical, and market conditions such as recessions, wars such as the current conflict in Palestine and Ukraine, attacks in the Red Sea elections, interest rate changes, or cost inflation, may negatively affect the market price of our ordinary shares, regardless of our actual operating performance. In addition, in the past, following periods of volatility in the overall market and the market price of a particular company’s securities, securities class action litigation has often been instituted against these companies. Such litigation, if instituted against us, could result in substantial costs and a diversion of our management’s attention and resources, which would seriously harm our business, financial condition and results of operations. An active, liquid trading market for our securities may not be sustained, which could make it difficult for security holders to sell their securities. An active trading market for our securities may not be sustained. As a result, fewer securities are actively traded in the public market, which reduces the liquidity of our securities. The lack of an active trading market could impair our security holders’ ability to sell their securities at the desired time or at a price considered reasonable. Further, an inactive trading market may impair our ability to raise capital by selling securities in the future, and may impair our ability to enter into strategic relationships or acquire companies or technologies using shares of our securities as consideration. Our ordinary shares and warrants are expected to be listed on the Nasdaq Global Market, or Nasdaq, under the symbols “OMNI” and “OMNIW,” respectively. If we fail to satisfy the continued listing standards of Nasdaq, however, we could be de -listed, which would negatively impact the price and liquidity of our securities. Sales of